nic/rSO 2 cerebral), and data were analyzed using a linear mixed effect model. Results: Fifty neonates with a median gestational age of 28 weeks (range 23-32), a birth weight of 1,118 ± 284 g (mean ± SD), and a hematocrit of 26 ± 2% (mean ± SD) were studied. During feedings, SCOR decreased significantly from baseline (0.72 ± 0.17 to 0.69 ± 0.17, p = 0.043). With feedings, there was a trend of decreased splanchnic rSO 2 (47 ± 11 to 45 ± 10, p = 0.057) and no change in cerebral rSO 2 (66 ± 8 to 66 ± 7, p = 0.597). Conclusions: VLBW infants with a hematocrit ≤ 28% had a decrease in SCOR and a trend towards decreased splanchnic rSO 2 with enteral feedings.
ciated with PRBC transfusions, an increasing number of premature neonates with anemia receive few if any PRBC transfusions and can remain anemic throughout their NICU hospitalization [7] . The implications of the pathophysiological status of prolonged anemia in the preterm infant is not well understood, especially at times of increased metabolic demand, such as enteral feedings. For instance, it has been reported that anemia can be associated with increased odds of developing NEC, independent of RBC transfusion [4] .
Near-infrared spectroscopy (NIRS) has been used in premature infants to evaluate changes in the perfusion and oxygenation of body tissues, including the brain and mesentery [8] [9] [10] . NIRS regional oxygen saturations (rSO 2 ) reflect a balance of tissue oxygen supply and demand, which may be altered by pathologic states such as anemia or NEC [11] . A prior study reported that mesenteric rSO 2 and superior mesenteric artery Doppler flow velocity increased concordantly with bolus feedings [8] . In a study utilizing a piglet model, low abdominal NIRS readings identified piglets in the process of developing NEC. The authors suggested that NIRS could be a means for early detection of NEC in human neonates [12] .
The splanchnic-cerebral oxygenation ratio (SCOR) has been proposed as a means of predicting mesenteric ischemia in neonates. The SCOR compares the splanchnic oxygenation to cerebral oxygenation as a reference, because cerebral autoregulation typically minimizes changes in brain oxygenation during events that affect splanchnic oxygenation [13] . SCOR was used to assess stable premature neonates on full enteral feedings, and was found to be significantly increased following enteral feedings [9] . However, it is not known whether anemia affects splanchnic rSO 2 or SCOR during enteral feedings, a time of increased metabolic demand, in very low birth weight (VLBW) premature infants. Therefore, we designed the present study to test the hypothesis that VLBW neonates with a hematocrit ≤ 28% would have a decrease in splanchnic rSO 2 and SCOR during enteral feedings.
Materials and Methods

Subjects
Neonates admitted to the University of Utah Hospital and Intermountain Medical Center NICUs were screened for study eligibility between September 2012 and January 2015. The study protocol and informed consent documents were approved by the IRB of both the University of Utah and Intermountain Health Care.
Prospective study patients were deemed eligible if they were born ≤ 32 weeks and were ≤ 12 weeks of age at the time of the study, were hemodynamically stable (no mechanical ventilation, vasopressors, or sepsis at the time of monitoring), and tolerating enteral feedings without intravenous fluid support. The eligibility criteria also included a hematocrit ≤ 28% prior to monitoring. At the time of this study infants were typically not transfused until they reached a hematocrit of 25-30% for those on nasal cannula and 20-25% for those on room air, based on a transfusion protocol. Infants were ineligible if they had multiple congenital anomalies or previous NEC (Bell's stage II disease or above).
NIRS Monitoring
After informed parental consent was obtained, infants were monitored using an INVOS 5100 C-4 (Covidien, Dublin, Ireland) NIRS monitor. Neonatal probes were placed according to Covi- Values are mean ± SD, n (%), or median (range) dien INVOS OxyAlert TM protocols on intact skin over the right or left frontal area (cerebral rSO 2 ) and the infraumbilical area of the abdomen (splanchnic rSO 2 ). The probe positions were not altered for the duration of the monitoring. The infants were monitored continuously for 24 h, with data collected for cerebral rSO 2 and splanchnic rSO 2 . Bedside nursing staff noted the feeding times on the INVOS monitor and on the bedside flow sheet. No changes were made to the infant's routine care during the monitoring except as clinically indicated. Other events recorded by bedside nursing staff included repositioning of the infant and obtaining the infants weight. None of the rSO 2 values were available to the treatment team and no clinical decisions were made using the data.
Data Collection
Clinical data were collected at the time of the study and then at the time of discharge, including birth weight, gestational age, APGAR scores, hematocrit prior to monitoring, and feeding type, volume, and length. Any episodes of NEC during the infant's hospital course were also recorded.
Following the 24-h period of observation, the rSO 2 data were downloaded for analyses. Mean rSO 2 (cerebral and splanchnic) were calculated for 30-min periods prior to each feeding, for the duration of each feeding, and for a 30-min period after each feeding. The SCOR was calculated (rSO 2 splanchnic/rSO 2 cerebral) for the baseline, feeding, and postfeeding time frames for each feeding instance using the mean rSO 2 .
Statistical Analysis
Descriptive statistics were used to summarize the demographics and clinical characteristics of the patients. Mean ± standard deviation (SD) or median and range (min.-max.) were used to summarize continuous variables across observed time periods (baseline, feeding, and postfeeding), and count and frequency were used for categorical values. The parametric correlation between the average change in SCOR during feedings versus the average baseline value was calculated using the Pearson correlation coefficient.
Linear mixed effect models were used to assess if there was a statistically significant association between each outcome and observed feeding time. The outcome variables were defined as the average SCOR, average cerebral rSO 2 , and average splanchnic rSO 2 , with the time of the observation (baseline, feeding, and postfeeding), hematocrit as either the continuous measure or binary variable, and gestational age as the predictor. Patients were included as a random effect to account for correlation of the outcomes between the different time points. A sample size of 50 patients was selected to facilitate a reasonable enrollment period and was based on the number of infants <32 weeks typically admitted to our NICUs and rates of anemia.
Statistical analyses were performed with SAS 9.4 (SAS Institute Inc., Cary, NC, USA). All p values were 2-sided and were deemed significant if <0.05.
Results
Fifty-two patients were enrolled in the study, of which 2 were subsequently excluded: 1 because the patient did not meet inclusion criteria and 1 who had incomplete rSO 2 data. The remaining 50 completed the study and are included in the final data analysis.
The baseline demographic data are shown in Table 1 . All subjects were premature neonates with a median gestational age of 28 weeks (range 23-32), and mean birth weight of 1,118 ± 284 g (mean ± SD). All infants were on full enteral feedings, without IV fluid support, and the majority were fed breast milk fortified to 24 kcal/oz. The average hematocrit at the time of study was 26.3 ± 1.6%. Three infants (6%) developed medical NEC during their hospitalization and none required surgical intervention.
The NIRS results from mixed effect models are shown in Table 2 . The mean average baseline SCOR decreased significantly during feedings (-0.03 ± 0.01, p = 0.043). There was no significant change noted in the cerebral rSO 2 . Even though it did not reach statistical significance, there was a trend (-1.70 ± 0.88, p = 0.057) toward decreased splanchnic rSO 2 during feedings. There was no significant difference between baseline and postfeeding SCOR (-0.003 ± 0.02, p = 0.839), cerebral rSO 2 (+0.57 ± 0.71), and splanchnic rSO 2 (+0.16 ± 1.1). The mixed effect model demonstrated no significant association between SCOR and gestational age at birth ( p = 0.748) and hema- tocrit as a continuous variable ( p = 0.605), or when divided into groups of hematocrit <25 and >25 ( p = 0.933). The average SCOR ranged from 0.26 to 1.51, with an interquartile range of 0.61-0.83. The change in SCOR during feeding was inversely related to the baseline value ( r = 0.31, p = 0.028). The infants with the lowest SCOR at baseline had the largest decrease in SCOR with feedings.
Discussion
This study is the first to utilize NIRS to evaluate the effect of bolus feedings upon SCOR in stable VLBW neonates (gestational age ≤ 32 weeks) with a hematocrit ≤ 28%. The most important finding is that SCOR decreased during enteral feedings in this population. The SCOR change was secondary to a decrease in splanchnic rSO 2 with feedings, while cerebral rSO 2 remained unchanged from baseline measurements. Furthermore, following feedings there was no increase in splanchnic rSO 2 or SCOR when compared to baseline values.
The baseline cerebral rSO 2 values were consistent with prior published values in preterm neonates with similar hematocrit levels, and somewhat lower than published values in babies with higher hematocrits [14, 15] . Cerebral rSO 2 values demonstrated no significant change with feedings. However, in contrast to earlier study results, we found both a trend in decreased splanchnic rSO 2 and a significant decrease in SCOR with feedings [9, 16] . A prior study by Dave et al. [9] evaluating nonanemic preterm infants with NIRS demonstrated an increased SCOR of 0.08 with feedings. We demonstrated a decreased SCOR of 0.03 with feedings in anemic VLBW infants. The total difference between the SCOR increase noted in nonanemic preterm neonates and the SCOR decrease seen in anemic preterm neonates was 0.11. Importantly, the mean hematocrit in the study by Dave et al. [9] was 37% compared to the mean hematocrit of 26% in our study. The difference noted between these 2 studies suggests that preterm infants with anemia have less ability to cope with the increased metabolic demands associated with feedings. Whether this SCOR difference is solely related to the lower hematocrit is unknown, and other factors, such as the elevation of our study center (4,500 ft), should be considered.
Our study was conducted at elevation while prior studies were performed at locations near sea level. We speculate that if altitude played a significant role our baseline saturations and SCOR would have been lower than those seen previously. Our average splanchnic and cerebral saturations were similar at baseline to previous studies [9] , suggesting that altitude did not play a major role in the lower SCOR seen with feedings.
Importantly, infants with the lowest SCOR at baseline also had the largest decrease in SCOR with feedings. We postulate that babies with lower baseline SCOR values experience more pathophysiologic effects secondary to anemia. Because of this they are less able to compensate during times of increased metabolic demand, such as enteral feedings, resulting in a SCOR decrease with feedings.
There was a high degree of interindividual variability of baseline SCOR, with a range of 0.26-1.51. The interquartile range was 0.61-0.83, which was similar to the interquartile ranges reported in prior studies of preterm infants [9, 17] . In this study, SCOR values were consistent with those seen in other premature infant cohorts, but were lower than values seen in term infants. [9, 18] . A SCOR <0.75 and a splanchnic rSO 2 <56% have been shown to predict gut ischemia in neonates [17, 19] . In this study, the SCOR values of 0.72 (baseline) and 0.69 (feedings), and the splanchnic rSO 2 values of 47% (baseline) and 45% (feedings) all fall below the boundary values for the prediction of splanchnic ischemia [17] . This suggests that preterm neonates with a hematocrit value ≤ 28% have a baseline level of intestinal hypoperfusion that could then worsen during enteral feedings, potentially increasing their risk of feeding intolerance or NEC.
Another important observation is that we did not find an association between hematocrit prior to NIRS monitoring and the change in SCOR. We speculate that this could be related to the different hematocrit levels at which babies develop symptomatic anemia. Typical clinical practice for transfusion treatment utilizes hematocrit cutoffs, but not all babies with a low hematocrit level have "symptomatic" anemia or improve with RBC transfusion [20] . Although additional studies are needed, future use of NIRS could involve utilizing rSO 2 and SCOR trends to guide the diagnosis of "symptomatic" anemia.
Three babies (6%) in our study developed medical NEC during their NICU hospitalization. One of these patients had a hematocrit of ≤ 28% when NEC occurred. The SCOR change seen in this baby with feedings was -0.05. This is slightly larger than the average SCOR change of -0.03. Lastly, the incidence of NEC in our study population was similar to the incidence in our NICU during the same time period.
One limitation of our study is that matched control infants without anemia were not evaluated at our centers. Also, the size of the SCOR change was relatively small, but when the decrease was compared with the expected in-crease a larger change was observed. The clinical significance of this is not known as the incidence of NEC was unchanged in our cohort. Only hemodynamically stable premature infants were included in this study because of the concern that hemodynamic instability would have an impact on splanchnic perfusion independent of feedings. This may have decreased the presence of abdominal pathologies in our cohort [21] . Another limitation is that splanchnic rSO 2 has increased variability and changes in NIRS signal quality compared to other body sites. This is often due to the changing nature of intestinal contents, i.e., peristalsis, stool, and air [14, 22] . Due to these changes in signal quality, some feedings were not included in the analysis: for each patient studied a range of 4-759 feedings were included. In our study there was 22% variability in splanchnic rSO 2 and 11% variability in cerebral rSO 2 . This is comparable with a prior study that demonstrated 16-23% variability in splanchnic rSO 2 , compared to 3-4% variability in cerebral rSO 2 [22] . The increased cerebral variability seen is likely to be due to the long observation period utilized in this study, as the observation period encompassed times of clinical change, such as enteral feedings, which were avoided in the prior study. To account for the high level of variability in splanchnic rSO 2 , the SCOR was utilized to improve the reliability of the splanchnic rSO 2 by comparing it to the cerebral rSO 2 , which has low variability secondary to cerebral autoregulation. We also had some infants whose splanchnic rSO 2 values were higher than their cerebral rSO 2 values. The cause of this is unknown, but could be related to changes in oxygen demand.
In conclusion, this observational study demonstrated that preterm neonates with a hematocrit ≤ 28% had a significant decrease in SCOR from baseline during enteral feedings, suggesting that anemic neonates have a lower physiologic capacity to accommodate times of increased metabolic demand. This could lead to increased intestinal hypoperfusion and an increased risk of feeding intolerance and NEC. Based on these data, we speculate that NIRS could be used as an additional tool to better inform clinicians about splanchnic oxygenation in patients at risk for NEC. For example, an infant with either no change or a decrease in SCOR during feedings could prompt further evaluation of feeding tolerance, and indicate the potential need for transfusion and/or erythropoietic agents. Additional studies are needed to determine the efficacy of NIRS as a tool to monitor infants at risk for NEC.
